Stories about Advanced

Subscribe to Advanced

26.11.2020 – 17:37

Merck KGaA
European Medicines Agency Validates Application for Tepotinib for the Treatment of Advanced NSCLC with METex14 Skipping Alterations

Darmstadt, Germany (ots/PRNewswire) - Merck, a leading science and technology company, today announced that the European Medicines Agency (EMA) has validated for review, the application for tepotinib for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial ...

more
01.11.2019 – 10:16

REstore
RESTORE 1st Advanced Therapies Science Meeting

Berlin (ots/PRNewswire) - 25th-26th November 2019, Berlin RESTORE-Health by Advanced Therapies invites you to join the First Advanced Therapies Science Meeting (ATSM), an EACCME® accredited event, which will be held at the Maritim Hotel, Stauffenbergstraße in Berlin from the 25th - 26th November 2019. Advanced Therapies are one of the most recent and significant advances in medicine. They include gene and cell therapies ...

more
28.10.2019 – 10:10

Top Aces Inc
Top Aces Receives Notice of IDIQ Award

Mesa, Arizona (ots/PRNewswire) - Advanced adversary air training leader ideally positioned to be key provider - Top Aces Corp. is pleased to announce that it has been selected as a winner under the U.S. Air Force Combat Air Force Contracted Air Support contract. This contract provides a vehicle through which Top Aces can offer it's highly advanced adversary air capabilities and compete for individual tenders at twelve ...

more
05.09.2019 – 09:00

Yanfeng Automotive Interiors

Yanfeng pioneers Hygiene Technologies for Shared Mobility in Smart Cabins / Advanced, health-focused smart technologies for a premium user experience

more
14.02.2019 – 09:00

Debiopharm International SA

Debiopharm International SA Initiates FUZE, a Clinical Trial Phase II study evaluating Debio 1347 in Advanced Solid Tumors harboring an FGFR fusion

more
30.01.2019 – 08:12

ForaCare Suisse AG

2
ForaCare Suisse AG forms service-oriented partnership with B. Braun

more
21.12.2018 – 20:02

Merck KGaA
Merck and Pfizer Provide Update on JAVELIN Ovarian 100 Trial of Avelumab in Previously Untreated Advanced Ovarian Cancer

Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for US, Canada and UK-based media Merck and Pfizer Inc. (NYSE: PFE) today announced that data from a planned interim analysis of the Phase III JAVELIN Ovarian 100 study of avelumab* did not support the study's initial hypothesis, and therefore the ...

more

1